The 3rd update meeting on oncotype DX assays


Peter R. Carroll, MD, MPHRefined Risk Assessment Leads to Refined Treatment for Prostate Cancer

Peter R. Carroll, MD, MPH
Professor and Chair, Ken and Donna Derr - Chevron Distinguished Professor Department of Urology, Associate Dean, Director of Clinical Services and Strategic Planning UCSF - Helen Diller Comprehensive Cancer Center University of California, San Francisco

אינך רואה את ההרצאה?, לחץ כאן
 
SignifiCast.come-Med ערוץ החדשות הרפואיות של ישראל